Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 24663824)


Involvement of CD74 in head and neck squamous cell carcinomas.

Kindt N, Lechien JR, Nonclercq D, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2014 Jun;140(6):937-47. doi: 10.1007/s00432-014-1648-9. Epub 2014 Mar 25.


Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.

Kindt N, Laurent G, Nonclercq D, Journé F, Ghanem G, Duvillier H, Gabius HJ, Lechien J, Saussez S.

Int J Oncol. 2013 Jul;43(1):185-93. doi: 10.3892/ijo.2013.1944. Epub 2013 May 16.


Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.

Kindt N, Preillon J, Kaltner H, Gabius HJ, Chevalier D, Rodriguez A, Johnson BD, Megalizzi V, Decaestecker C, Laurent G, Saussez S.

J Cancer Res Clin Oncol. 2013 May;139(5):727-37. doi: 10.1007/s00432-013-1375-7. Epub 2013 Jan 25.


Persistent Krüppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma.

Tai SK, Yang MH, Chang SY, Chang YC, Li WY, Tsai TL, Wang YF, Chu PY, Hsieh SL.

Cancer Sci. 2011 Apr;102(4):895-902. doi: 10.1111/j.1349-7006.2011.01859.x. Epub 2011 Mar 4.


Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.

Cheng RJ, Deng WG, Niu CB, Li YY, Fu Y.

Int J Gynecol Cancer. 2011 Aug;21(6):1004-12. doi: 10.1097/IGC.0b013e31821c45b7.


CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.

Zheng YX, Yang M, Rong TT, Yuan XL, Ma YH, Wang ZH, Shen LS, Cui L.

World J Gastroenterol. 2012 May 14;18(18):2253-61. doi: 10.3748/wjg.v18.i18.2253.


Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

Schröck A, Bode M, Göke FJ, Bareiss PM, Schairer R, Wang H, Weichert W, Franzen A, Kirsten R, van Bremen T, Queisser A, Kristiansen G, Heasley L, Bootz F, Lengerke C, Perner S.

Carcinogenesis. 2014 Jul;35(7):1636-42. doi: 10.1093/carcin/bgu094. Epub 2014 Apr 17.


Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.

Fan H, Hall P, Santos LL, Gregory JL, Fingerle-Rowson G, Bucala R, Morand EF, Hickey MJ.

J Immunol. 2011 Apr 15;186(8):4915-24. doi: 10.4049/jimmunol.1003713. Epub 2011 Mar 16.


Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.

Marsh LM, Cakarova L, Kwapiszewska G, von Wulffen W, Herold S, Seeger W, Lohmeyer J.

Am J Physiol Lung Cell Mol Physiol. 2009 Mar;296(3):L442-52. doi: 10.1152/ajplung.00525.2007. Epub 2009 Jan 9.


Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.

Richard V, Kindt N, Decaestecker C, Gabius HJ, Laurent G, Noël JC, Saussez S.

Oncol Rep. 2014 Aug;32(2):523-9. doi: 10.3892/or.2014.3272. Epub 2014 Jun 16.


CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder.

Choi JW, Kim Y, Lee JH, Kim YS.

Int J Urol. 2013 Feb;20(2):251-5. doi: 10.1111/j.1442-2042.2012.03128.x. Epub 2012 Aug 21.


Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.

Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M.

Clin Cancer Res. 1999 Apr;5(4):775-82.


Macrophage migration inhibitory factor inhibits the migration of cartilage end plate-derived stem cells by reacting with CD74.

Xiong CJ, Huang B, Zhou Y, Cun YP, Liu LT, Wang J, Li CQ, Pan Y, Wang H.

PLoS One. 2012;7(8):e43984. doi: 10.1371/journal.pone.0043984. Epub 2012 Aug 27. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/a5edef40-e46d-4810-9008-dbda429ccc2c.


Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.

Ye L, Sun PH, Malik MF, Mason MD, Jiang WG.

J Cancer Res Clin Oncol. 2014 Jun;140(6):957-67. doi: 10.1007/s00432-014-1650-2. Epub 2014 Mar 26.


Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.

Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, Kawakami Y, Toda M.

J Cell Sci. 2012 Jul 1;125(Pt 13):3210-20. doi: 10.1242/jcs.102210. Epub 2012 Mar 27.


Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.

Chen CY, Chiou SH, Huang CY, Jan CI, Lin SC, Hu WY, Chou SH, Liu CJ, Lo JF.

J Pathol. 2009 Nov;219(3):347-55. doi: 10.1002/path.2604.


Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Oh SH, Kim WY, Lee OH, Kang JH, Woo JK, Kim JH, Glisson B, Lee HY.

Cancer Sci. 2012 Jul;103(7):1259-66. doi: 10.1111/j.1349-7006.2012.02301.x. Epub 2012 May 25. Erratum in: Cancer Sci. 2012 Aug;103(8):1600.


Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.

Menéndez ST, Rodrigo JP, Allonca E, García-Carracedo D, Alvarez-Alija G, Casado-Zapico S, Fresno MF, Rodríguez C, Suárez C, García-Pedrero JM.

J Pathol. 2010 Aug;221(4):402-10. doi: 10.1002/path.2722.


Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.

Yan M, Xu Q, Zhang P, Zhou XJ, Zhang ZY, Chen WT.

BMC Cancer. 2010 Aug 17;10:437. doi: 10.1186/1471-2407-10-437.


Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.

Riedel F, Götte K, Hörmann K, Grandis JR.

Adv Otorhinolaryngol. 2005;62:103-20.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk